NCT07517055

Brief Summary

Deep infiltrating endometriosis (DIE) of the rectum and rectosigmoid colon represents one of the most severe forms of endometriosis and often requires surgical management when symptomatic and unresponsive to medical therapy. Accurate preoperative assessment of lesion size, extent, and depth of bowel infiltration is essential to guide surgical planning and minimize complications. Transvaginal ultrasound (TVUS) is the first-line imaging technique for the diagnosis of pelvic endometriosis and has high diagnostic accuracy for detecting rectosigmoid lesions. However, its ability to precisely assess infiltration depth and guide the choice of surgical technique may be limited by anatomical distortion and technical factors. Intraoperative ultrasound (IO-US) is a real-time imaging modality that can be performed during laparoscopic surgery after adhesiolysis, allowing direct evaluation of bowel lesions. It may improve the assessment of lesion characteristics and support intraoperative decision-making, potentially reducing unnecessary bowel resections. This prospective single-center comparative study aims to evaluate the agreement between preoperative TVUS and intraoperative ultrasound in measuring rectal and rectosigmoid DIE nodules. Secondary objectives include assessing measurement differences, identifying factors associated with discordance, and evaluating the reproducibility of ultrasound measurements. The findings of this study may improve preoperative counseling, optimize surgical planning, and support the integration of intraoperative ultrasound into the management of bowel endometriosis.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
23mo left

Started Apr 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Apr 2026Jul 2028

First Submitted

Initial submission to the registry

April 1, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2027

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2028

Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

April 1, 2026

Last Update Submit

April 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement Between TVUS and IO-US Measurements

    Agreement between preoperative transvaginal ultrasound (TVUS) and intraoperative ultrasound (IO-US) in measuring rectal and rectosigmoid deep infiltrating endometriosis nodules, assessed using the intraclass correlation coefficient (ICC).

    12 months

Secondary Outcomes (3)

  • Measurement Difference Between TVUS and IO-US

    12 months

  • Agreement Analysis Between TVUS and IO-US

    12 months

  • Intraobserver and Interobserver Reproducibility

    12 months

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with suspected deep infiltrating endometriosis of the posterior compartment involving the rectum or rectosigmoid colon who are scheduled for surgical treatment.

You may qualify if:

  • Women aged 18 to 55 years
  • Clinical and/or imaging suspicion of rectal or rectosigmoid deep infiltrating endometriosis (DIE)
  • Indication for laparoscopic or robotic surgery for DIE
  • Ability and willingness to provide written informed consent

You may not qualify if:

  • Previous bowel resection for deep infiltrating endometriosis
  • Active inflammatory bowel disease
  • Pregnancy
  • Technical inability to perform transvaginal or intraoperative ultrasound
  • Refusal or withdrawal of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Giorgia Gaia

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2026

First Posted

April 8, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

April 7, 2027

Study Completion (Estimated)

July 7, 2028

Last Updated

April 8, 2026

Record last verified: 2026-03